ImmunoGen

USA

ImmunoGen

830 Winter Street

Daniel M. Junius — President and Chief Executive Officer
John M. Lambert, Ph.D. — Executive Vice President, Research and Development and Chief Scientific Officer
Charles Morris, M.B., Ch.B., M.R.C.P. — Executive Vice President and Chief Development Officer
Gregory Perry — Executive Vice President and Chief Financial Officer
Godfrey Amphlett, Ph.D. — Vice President, Process and Analytical Development
Craig Barrows — Vice President, General Counsel and Secretary
Robert J. Lutz, Ph.D. — Vice President, Translational Research and Development
James O`Leary, M.D. — Vice President and Chief Medical Officer
Peter Williams — Vice President, Business Development
Theresa Wingrove, Ph.D. — Vice President, Regulatory Affairs

Oncology

Production

Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer

IMGN

Stephen C. McCluski — Chairman
Daniel M. Junius
Mark Goldberg, M.D.
Dean Mitchell
Nicole Onetto, M.D.
Kristine Peterson
Howard H. Pien
Mark Skaletsky
Joseph J. Villafranca, Ph.D.
Richard J. Wallace

1.2400

Cell Technologies, Homogeneous antibodies, Devices, Technologies, Pharmaceuticals, Chemistry